63
Views
35
CrossRef citations to date
0
Altmetric
Original Articles

Effect of Botulinum Toxin Type A on Nasal Symptoms in Patients with Allergic Rhinitis: A Double-blind, Placebo-controlled Clinical Trial

, , , &
Pages 1060-1063 | Received 02 Dec 2002, Accepted 28 Feb 2003, Published online: 01 Apr 2016

REFERENCES

  • Skoner DP. Allergic rhinitis: definition, epidemiology, pathophysiology, detection and diagnosis. J Allergy Clin Immunol 2001; 108: S2–8.
  • Aberg N. Asthma and allergic rhinitis in Swedish conscripts. Clin Exp Allergy 1989; 19: 59–63.
  • Shaari CM, Sanders I, Wu BL, Biller HF. Rhinorrhea is decreased in dogs after nasal application of botulinum toxin. Otolaryngol Head Neck Surg 1995; 112: 566–71.
  • Holmberg K, Bake B, Pipkorn U. Reflex activation in allergen-induced nasal mucosal vascular reactions. Acta Otolaryngol (Stockh) 1989; 108: 130–5.
  • Schantz EJ, Johnson EA. Properties and uses of botulinum toxin and other microbial neurotoxins in medicine. Microbiol Rev 1992; 56: 80–99.
  • Jankovic J, Brin MF. Therapeutic uses of botulinum toxin. N Engl J Med 1991; 324: 1186–94.
  • Drobik C, Laskawi R. Frey's syndrome: treatment with botulinum toxin. Acta Otolaryngol (Stockh) 1995; 115: 459–61.
  • Koriwchak MJ, Netterville JL, Snowden T, Courey M, Ossoff RH. Alternating unilateral botulinum toxin type A (BOTOX) injections for spasmodic dysphonia. Laryngoscope 1996; 106: 1476–81.
  • Lee MC. Spasmodic torticollis: medical and botulinum toxin A treatment. Yonsei Med J 1992; 33: 289–93.
  • Kim KS, Kim SS, Yoon JH, Han JW. The effect of botulinum toxin type A injection for intrinsic rhinitis. J Laryngol Otol 1998; 112: 248–51.
  • Rohrbach S, Laskawi R. Minimally invasive application of botulinum toxin type A in nasal hypersecretion. ORL J Otorhinolaryngol Relat Spec 2001; 63: 382–4.
  • Rohrbach S, Olthoff A, Laskawi R, Giefer B, Götz W. Botulinum toxin type A induces apoptosis in nasal glands of guinea pigs. Ann Otol Rhinol Laryngol 2001; 110: 1045–50.
  • Scott AB, Suzuki D. Systemic toxicity of botulinum toxin by intramuscular injection in the monkey. Mov Disord 1988; 3: 333–5.
  • Mygind N. Mediators of nasal allergy. J Allergy Clin Immunol 1982; 70: 149–59.
  • Borodic GE, Ferrante RJ, Pearce LB, Alderson K. Pharmacology and histology of the therapeutic application of botulinum toxin. In: Jankovic J, Hallett M, eds. Therapy with botulinum toxin. New York: Marcel Dekker, 1994: 119–59.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.